» MHA HIIN 3.0 MEMBER: No cost to register
» MHA MEMBER: $150 per connection
» ALL OTHERS: $250 per connection
All invoices must be paid in order to receive log-on information prior to the webinar.
12:15 p.m. - Welcome
12:20 p.m. Antibiotics Stewardship Program led by Steve Tremain, MD, Cynosure Health
12:50 p.m. Q&A
1:00 p.m. Sepsis led by Maryanne Whitney, Cynosure Health
1:20 p.m. - Q&A
1:30 p.m. Adjourn
Join us on Monday, June 4, 2018, for an informative webinar discussing the Antibiotics Stewardship Program | Sepsis Provided by the MHA HIIN 3.0 (Hospital Improvement Innovation Network)
This educational activity is jointly provided by AXIS Medical Education and the Mississippi Hospital Association
Physicians, Nurse Practitioners, Pharmacists, Nursing Staff, Hospital Leaders
Describe the purpose of antibiotic stewardship program.
Outline the steps to begin your antibiotic stewardship program.
Identify Innovative Approaches to AS programs.
Define small tests of change to measure progress in your AS program.
Explain the critical elements of early identification and treatment for sepsis.
Improving the use of antibiotics is an important patient safety and public health issue as well as a national priority. A growing body of evidence demonstrates that hospital-based programs dedicated to improving antibiotic use, commonly referred to as “Antibiotic Stewardship Programs (ASPS)” can both optimize the treatment of infections and reduce adverse events associated with antibiotic use.
Sepsis is the body’s extreme response to an infection. It is life-threatening and without timely treatment can rapidly cause tissue damage, organ failure, and death. Sepsis is a medical emergency. Time matters.
The lead speakers for the webinar are two healthcare professionals from the Cynosure Health Team. Steve Tremain, MD, Physician Advisor, will lead the ASP discussion. Maryanne Whitney, Improvement Advisor, will lead the Sepsis topic. You can learn more about each speaker by going to www.cynosurehealth.org and clicking on THE TEAM tab.
Steve Tremain is a Physician Improvement Advisor with Cynosure Health. Board certified for 35 years in Family Medicine and now retired from active clinical practice, Dr. Tremain worked as a hospital-based clinician and teacher, and served as Chief Medical Officer for a large integrated public system for over 20 years. He was the executive sponsor for improvement teams that were awarded mentor status by the Institute for Healthcare Improvement in the areas of medication reconciliation, rapid response teams, and ventilator associated pneumonia.
Currently Dr. Tremain works as an national and international Improvement Advisor and serves as the national clinical lead or co-lead for the American Hospital Association/HRET HIIN efforts to improve antibiotic stewardship and to reduce harm from adverse drug events, VTE, sepsis, and C.difficile. In addition, he teaches and consults regarding the culture of safety, process reliability, leadership and physician engagement throughout the United States and Canada.
Steve is a Certified Physician Executive and a Fellow of the American College of Physician Executives. He earned his MD degree from the UCLA School of Medicine.
Maryanne Whitney is an Improvement Advisor with Cynosure Health and she is a Clinical Nurse Specialist in Critical Care, who currently works as a case manager for CV surgery patients and a hospital supervisor in Northern California. Previously, Maryanne was a nursing leader in a large integrated health system as the ICU/ Stepdown Manager, CNS and nursing educator and worked to successfully implement, Sepsis, RRT and ICU liberation Bundles within her organization.
Currently with Cynosure Health, Maryanne works as a national Improvement Advisor and serves as the national clinical lead or co-lead for the American Hospital Association/HRET HIIN efforts to improve airway safety, and to reduce harm from sepsis, ventilator associated events, delirium and adverse drug events.
Maryanne earned her Masters on Science in Nursing and Clinical Nurse Specialist certification at San Francisco State University.
CONTINUING EDUCATION | Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and Mississippi Hospital Association. AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation for Physicians
AXIS Medical Education designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation for Pharmacists
This knowledge-based activity is approved for 1.25 contact hours of continuing pharmacy education credit JA4008106-9999-18-033-L01-P.
Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 1.25 contact hours.
AXIS Contact Information
For information about the accreditation of this program please contact AXIS at email@example.com.
Disclosure of Conflicts of Interest
AXIS Medical Education requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by AXIS for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty, Steve Tremain, M.D. and Maryanne Whitney reported no financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.
The planners and managers, Robin Powell, Dee Morgillo, MEd, CHCP, Holly Hampe, D.Sc., RN, MHA, MRM, and Ronal Viggiani, MD reported no financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
DISLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Requirements for credit:
» Attend/participate in the educational activity and review all course materials.
» Complete the CE Declaration form online by 11:59 pm ET July 6, 2018. Instructions will be provided. If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.
» Upon successful completion of the online form, your statement of completion will be presented to you to print.